<DOC>
	<DOCNO>NCT00193362</DOCNO>
	<brief_summary>The purpose study compare effectiveness three-drug combination paclitaxel , carboplatin , gemcitabine two-drug combination gemcitabine vinorelbine patient advance Non-Small Cell Lung Cancer</brief_summary>
	<brief_title>Study Paclitaxel , Carboplatin , Gemcitabine Versus Gemcitabine Vinorelbine Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Upon determination eligibility , patient randomly assign one two treatment arm : - Paclitaxel + Carboplatin + Gemcitabine - Gemcitabine + Vinorelbine For ever 2 patient treat , 1 receive treatment A ( Paclitaxel + Carboplatin + Gemcitabine ) 1 receive treatment B ( Gemcitabine + Vinorelbine ) . The study blind patient doctor know treatment assign .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>To include study , must meet following criterion : Nonsmall cell bronchogenic carcinoma Newly diagnose unresectable stage IIIB stage IV disease Patients stage IIIB disease ineligible combined therapy Patients must measurable lesion definable Xray CT scan . No prior antineoplastic chemotherapy lung cancer prior study entry Age &gt; 18 year Able perform activity daily live minimal assistance Adequate bone marrow , liver kidney function Written inform consent must obtain prior study entry Patients must available treatment followup . You participate study follow apply : Female patient pregnant lactate History heart disease Serious active infection time treatment Other serious underlie medical condition Brain metastasis Patients without measurable disease Uncontrolled diabetes mellitus define random blood sugar &gt; 250mg/dL Dementia significantly alter mental status Significant peripheral neuropathy history physical examination . Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>